Abstract
Skin cancer is one of the most prevalent neoplasms worldwide, necessitating the development of innovative therapeutic approaches. Conventional biological models, such as monolayer cell cultures and animal testing, have significant limitations in replicating the complexity of the tumor microenvironment. In this context, "organ-on-a-chip" technology emerges as a promising alternative, enabl…